International audience
-
December 1, 2020 (v1)Journal articleUploaded on: December 4, 2022
-
2015 (v1)Journal article
Testing hepatotoxicity is a crucial step in the development and toxicological assessment of drugs and chemicals. Bio-activation can lead to the formation of metabolites which may present toxicity for the organism. Classical cytotoxic tests are not always appropriate and are often insufficient, particularly when non metabolically-competent cells...
Uploaded on: December 4, 2022 -
September 2022 (v1)Journal article
Cell response variability is a starting point in cancer drug resistance that has been difficult to analyze because the tolerant cell states are short lived. Here, we present fate-seq, an approach to isolate single cells in their transient states of drug sensitivity or tolerance before profiling. The drug response is predicted in live cells,...
Uploaded on: February 22, 2023 -
2022 (v1)Journal article
Cell response variability is a starting point in cancer drug resistance that has been difficult to analyze because the tolerant cell states are short lived. Here, we present fate-seq, an approach to isolate single cells in their transient states of drug sensitivity or tolerance before profiling. The drug response is predicted in live cells,...
Uploaded on: December 4, 2022 -
September 2022 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
October 2020 (v1)Journal article
Highlights d Fate-seq links the drug response of a single cell to its own transcriptomic profile d Fate-seq recovers variable cell decision information from unstructured variability d It identifies molecular factors causing the intrinsic resistance to cancer drugs d A TRAIL therapeutic efficacy profile is performed in HeLa cells as proof of concept
Uploaded on: December 4, 2022